
Bioorganic and Medicinal Chemistry Letters p. 1787 - 1790 (1998)
Update date:2022-08-03
Topics:
Chambers
Koch
Biggers
Ramchandani
Structural modification of 1 led to a series of 2-(4-hydroxy-7- chromanyl)benzoic acid LTB4 antagonists exemplified by 2 and 3. The use of an organostannane biaryl coupling, a non stereoselective reduction and a chromatographic resolution limited the utility of this synthetic route. To address these issues, a new synthetic route was developed utilizing a palladium catalyzed coupling of aryl oxazolines in tandem with a stereospecific enone reduction as key synthetic steps. Resolution was achieved by fractional crystallization of a (S)-(-)-α-methylbenzylamine salt.
View MoreWeifang Arylchem Chemical Co., LTD
Contact:86-536-5217866
Address:Development Zone, Shouguang, Shandong Province
Contact:+86-0311-84455288-844
Address:Mayu Industrial Park, Jinzhou, Hebei, China.
Contact:0091-265-2313036
Address:311, ATLANTIS HEIGHTS SARABHAI MAIN ROAD,VADIWADI ,VADODARA
Xiamen Huasing Chemicals Co.Ltd.
Contact:0086-592-6228397
Address:NO.24, Xinglin North 2nd Road,Jimei district
Shenzhen JYMed Technology Co.,Ltd.
website:http://www.jymedtech.com
Contact:+86-755-26612112
Address:1#8,9/F, Biomedicine innovation Industrial Park, No.14, Jinhui Road, Pingshan Sistrict, Shenzhen, China
Doi:10.1016/j.bmcl.2013.07.023
(2013)Doi:10.1021/ja962990n
(1997)Doi:10.1002/anie.201302815
(2013)Doi:10.1016/0031-9422(92)83296-B
(1992)Doi:10.1038/sj.bjp.0704611
(1957)Doi:10.3390/molecules18055697
(2013)